Cibus (CBUS) Other Non Operating Income (2016 - 2026)
Cibus (CBUS) posted Other Non Operating Income of -$17000.0 for Q4 2025, down 1800.0% sequentially from $1000.0 in Q3 2025, and down 104.8% YoY from $354000.0 in Q4 2024.
Cibus (CBUS) Other Non Operating Income (2016 - 2026) Analysis & Trends
Cibus has reported Other Non Operating Income for 10 years, with the latest figure at -$17000.0 in Q4 2025.
- Quarterly Other Non Operating Income fell 104.8% year-over-year to -$17000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $400000.0 (down 95.69% YoY) and the FY2025 annual result came in at $400000.0, down 95.69% from the prior year.
- Other Non Operating Income slipped to -$17000.0 in Q4 2025 per CBUS's latest filing, from $1000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $7.7 million in Q3 2024 and troughed at -$910000.0 in Q1 2023.
- A 5-year average of $990937.5 and a median of $327000.0 in 2022 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2023 and 2024: Other Non Operating Income sank 392.0% in 2023, then soared 979.68% in 2024.
- Over 5 years, Other Non Operating Income stood at $1.5 million in 2021, then slumped by 67.8% to $483000.0 in 2022, then sank by 85.3% to $71000.0 in 2023, then surged by 398.59% to $354000.0 in 2024, then slumped by 104.8% to -$17000.0 in 2025.
- According to Business Quant data, Other Non Operating Income over the past three periods registered -$17000.0, $1000.0, and -$23000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Cibus | 131.25 Mn | 110.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 150,000.00 |
| Dec 31, 2025 | -17,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | -23,000.00 |
| Mar 31, 2025 | 439,000.00 |
| Dec 31, 2024 | 354,000.00 |
| Sep 30, 2024 | 7.71 Mn |
| Jun 30, 2024 | 1.58 Mn |
| Mar 31, 2024 | -369,000.00 |
| Dec 31, 2023 | 71,000.00 |
| Sep 30, 2023 | -876,000.00 |
| Jun 30, 2023 | 1.32 Mn |
| Mar 31, 2023 | -910,000.00 |
| Dec 31, 2022 | 483,000.00 |
| Sep 30, 2022 | 300,000.00 |
| Jun 30, 2022 | 4.30 Mn |
| Jun 30, 2021 | 1.50 Mn |
| Mar 31, 2020 | -9,000.00 |
| Dec 31, 2019 | 35,000.00 |
| Sep 30, 2019 | -8,000.00 |